Cardioprotective effect of lycopene against isoproterenol-induced myocardial infarction in rats

Human and Experimental Toxicology

Volumn 32, Issue 5, 2013, Pages 492-503

  Ojha, S ^a   Goyal, S ^a   Sharma, C ^a   Arora, S ^a   Kumari, S ^b   Arya, D S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN AGRICULTURAL RESEARCH INSTITUTE   (India)

Author keywords

cardiac function; Carotenoid; ischemic injury; lycopene; oxidative stress

Indexed keywords

CATALASE; CREATINE KINASE MB; GLUTATHIONE; GLUTATHIONE PEROXIDASE; ISOPRENALINE; LACTATE DEHYDROGENASE; LYCOPENE; MALONALDEHYDE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART EDEMA; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE NECROSIS; HEART MUSCLE RELAXATION; HEART PROTECTION; HEART RATE; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

CARDIAC FUNCTION; CAROTENOID; ISCHEMIC INJURY; LYCOPENE; OXIDATIVE STRESS;

ANIMALS; CAROTENOIDS; CREATINE KINASE, MB FORM; GLUTATHIONE; HEART; HEMODYNAMICS; ISOPROTERENOL; LIPID PEROXIDATION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR;

RATTUS;

EID: 84878292104     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112454890     Document Type: Article

References (40)

1. Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2011 ; 8: 140-147
2. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovas Res. 2000 ; 47: 446-456
3. Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol-induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010 ; 644: 160-168
4. Tinkel J, Hassanain H, Khouri SJ. Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms. Cardiol Rev. 2012 ; 20: 77-83
5. Visioli F, Borsani L, Claudio G. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res. 2000 ; 47: 419-425
6. Hearse DJ.. Prospects for antioxidant therapy in cardiovascular medicine. Am J Med. 1991 ; 91: 118S - 121S
7. Hertog MGL, Feskens EJM, Hollam PCH, Katan MB, Kromhout D.. Dietary antioxidant flavonoids and risk of coronary heart diseases. The Zutphen Elderly Study. Lancet. 1993 ; 342: 1007-1020
8. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res. 2007 ; 73: 326-340
9. Krinsky NI. Overview of lycopene, carotenoids, and disease prevention. Proc Soc Exp Biol Med. 1998 ; 218: 95-100
10. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev. 1998 ; 1: 35-51
11. Bansal P, Gupta SK, Ojha SK, Nandave M, Mittal R, Kumari S, et al. Cardioprotective effect of lycopene in the experimental model of myocardial ischemia-reperfusion injury. Mol Cell Biochem. 2006 ; 289: 1-9
12. Anjos Ferreira AL, Russell RM, Rocha N, Placido Ladeira MS, Favero Salvadori DM, Oliveira Nascimento MC, et al. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment. Basic Clin Pharmacol Toxicol. 2007 ; 101: 16-24
13. Hsiao G, Fong TH, Tzu NH, Lin KH, Chou DS, Sheu JR. A potent antioxidant lycopene affords neuroprotection against microglia activation and focal cerebral ischemia in rats. In Vivo. 2004 ; 18: 351-356
14. Akbaraly NT, Faure H, Gourlet V, Favier A, Berr C. Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA study. J Gerontol A Biol Sci Med Sci. 2007 ; 62: 308-316
15. Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, Kardinaal AFM, et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 1997 ; 146: 618-626
16. Arab L, Steck S.. Lycopene and cardiovascular disease. Am J Clin Nutr. 2000 ; 71: 1691S - 1695S
17. Riccioni G, Mancini B, Di Ilio E, Bucciarelli T, D'Orazio N. Protective effect of lycopene in cardiovascular disease. Eur Rev Med Pharmacol Sci. 2008 ; 12: 183-190
18. Tavani A, Gallus S, Negri E, Parpinel M, La Vecchia C. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic Res. 2006 ; 40: 659-664
19. Kong KW, Khoo HE, Prasad KN, Ismail A, Tan CP, Rajab NF. Revealing the power of natural red pigment lycopene. Molecules. 2010 ; 15: 959-987
20. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985 ; 17: 291-306
21. Ojha SK, Nandave M, Arora S, Narang R, Dinda AK, Arya DS. Chronic administration of Tribulus terrestris Linn extract improves cardiac function and attenuates myocardial infarction in rats. Int J Pharmacol. 2008 ; 4: 1-10
22. Harada K, Futaka Y, Miwa A, Kaneta S, Fukushima H, Ogawa N. Effect of KRN 2391, a novel vasodilator, on various experimental angina models in rats. Jpn J Pharmacol. 1993 ; 63: 35-39
23. Mladenka P, Hrdina R, Bobrovová Z, Semecký V, Vávrová J, Holecková M, et al. Cardiac biomarkers in a model of acute catecholamine cardiotoxicity. Hum Exp Toxicol. 2009 ; 28: 631-640
24. Maron MS, Depierre JW, Manmerik B. Level of glutathione, glutathione reductase and glutathione-s-transferase activity in rat lung and liver. Biochem Biophys Acta. 1979 ; 82: 67-78
25. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Ann Biochem. 1979 ; 95: 351-358
26. Misra HP, Fridovich I. The oxidation of phenylhydrazine: superoxide and mechanisms. Biochem. 1976 ; 15: 681-687
27. Aebi H. Catalase. In: Bergmayer HE (ed) Methods of enzymatic analysis. 2nd ed. Vol 2. Academic Press, New York, 1974, pp. 213-215.
28. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte peroxidase. J Lab Clin Med. 1967 ; 2: 158-164
29. Lamprecht W, Stan F, Weisser H, Heinz F. Determination of creatine phosphate and adenosine triphosphate with creatine kinase. Methods of enzymatic analysis. Bergmeyer HU, ed. New York, NY: Academic Press ; 1974: 1776-1778.
30. Cabaud PG, Wroblewski F. Calorimetric measurements of lactic dehydrogenase activity of body fluids. Am J Clin Pathol. 1958 ; 3: 234-236
31. Lowry OH, Rosebrough NJ, Farr AI. Protein measurements with the folin-phenol reagent. J Biol Chem. 1951 ; 193: 265-275
32. Yeager JC, Iams SG. The hemodynamics of isoproterenol-induced cardiac failure in the rat. Cir Shock. 1981 ; 8: 151-163
33. Tappia PS, Heta T, Dhalla NS. Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys. 2001 ; 377: 85-92
34. Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996 ; 384: 240-246
35. Di Mascio P, Kaiser S, Sies H. Lycopene as the most effective biological carotenoid singlet oxygen scavenger. Arch Biochem Biophys. 1989 ; 274: 532-538
36. Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006 ; 218: 164-171
37. Stahl W, Sies H. Antioxidant activity of carotenoids. Mol Aspects Med. 2003 ; 24: 345-351
38. Woodall AA, Lee SW, Weesie RJ, Jackson MJ, Britton G. Oxidation of carotenoids by free radicals: relationship between structure and reactivity. Biochim Biophys Acta. 1997 ; 1336: 33-42
39. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 1995 ; 9: 1551-1558
40. Cruickshank JM, Dweyer GN.. β-Blocker brain concentrations in man. Eur J Clin Pharmacol. 1985 ; 28: 21-23